These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25755576)

  • 1. Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioacetamide-induced Rat Liver Fibrosis.
    Buko VU; Lukivskaya OY; Naruta EE; Belonovskaya EB; Tauschel HD
    J Clin Exp Hepatol; 2014 Dec; 4(4):293-301. PubMed ID: 25755576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
    Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
    Sombetzki M; Fuchs CD; Fickert P; Österreicher CH; Mueller M; Claudel T; Loebermann M; Engelmann R; Langner C; Sahin E; Schwinge D; Guenther ND; Schramm C; Mueller-Hilke B; Reisinger EC; Trauner M
    J Hepatol; 2015 Apr; 62(4):871-8. PubMed ID: 25463533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
    Fickert P; Hirschfield GM; Denk G; Marschall HU; Altorjay I; Färkkilä M; Schramm C; Spengler U; Chapman R; Bergquist A; Schrumpf E; Nevens F; Trivedi P; Reiter FP; Tornai I; Halilbasic E; Greinwald R; Pröls M; Manns MP; Trauner M;
    J Hepatol; 2017 Sep; 67(3):549-558. PubMed ID: 28529147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
    Lukivskaya O; Patsenker E; Lis R; Buko VU
    Eur J Clin Invest; 2008 May; 38(5):317-25. PubMed ID: 18380797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of ursodeoxycholic and norursodeoxycholic acid as substrates of the hepatic uptake transporters OATP1B1, OATP1B3, OATP2B1 and NTCP.
    König J; Klatt S; Dilger K; Fromm MF
    Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):81-6. PubMed ID: 22333292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin administration exacerbates thioacetamide-induced liver fibrosis in mice.
    Dai K; Qi JY; Tian DY
    World J Gastroenterol; 2005 Aug; 11(31):4822-6. PubMed ID: 16097051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats.
    Czechowska G; Celinski K; Korolczuk A; Wojcicka G; Dudka J; Bojarska A; Reiter RJ
    J Physiol Pharmacol; 2015 Aug; 66(4):567-79. PubMed ID: 26348081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects and mechanisms of ursodeoxycholic acid on isoprenaline-Induced myocardial fibrosis in mice].
    Li X; Han KQ; Shi YN; Men SZ; Li S; Sun MH; Dong H; Lu JJ; Ma LJ; Zhao M; Li D; Liu W
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):387-391. PubMed ID: 28219198
    [No Abstract]   [Full Text] [Related]  

  • 10. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.
    Halilbasic E; Fiorotto R; Fickert P; Marschall HU; Moustafa T; Spirli C; Fuchsbichler A; Gumhold J; Silbert D; Zatloukal K; Langner C; Maitra U; Denk H; Hofmann AF; Strazzabosco M; Trauner M
    Hepatology; 2009 Jun; 49(6):1972-81. PubMed ID: 19475687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats.
    El-Gendy ZA; El-Marasy SA; Ahmed RF; El-Batran SA; Abd El-Rahman SS; Ramadan A; Youssef SAH
    Heliyon; 2021 Jun; 7(6):e07159. PubMed ID: 34159266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans.
    Hofmann AF; Zakko SF; Lira M; Clerici C; Hagey LR; Lambert KK; Steinbach JH; Schteingart CD; Olinga P; Groothuis GM
    Hepatology; 2005 Dec; 42(6):1391-8. PubMed ID: 16317695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
    Krones E; Eller K; Pollheimer MJ; Racedo S; Kirsch AH; Frauscher B; Wahlström A; Ståhlman M; Trauner M; Grahammer F; Huber TB; Wagner K; Rosenkranz AR; Marschall HU; Fickert P
    J Hepatol; 2017 Jul; 67(1):110-119. PubMed ID: 28242240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling.
    Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Urbani G; Morretta E; Monti MC; Distrutti E; Fiorucci S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Nov; 1867(11):159218. PubMed ID: 35985473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats.
    Lee YH; Son JY; Kim KS; Park YJ; Kim HR; Park JH; Kim KB; Lee KY; Kang KW; Kim IS; Kacew S; Lee BM; Kim HS
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
    Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
    Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-acetyl cysteine (NAC), an organosulfur compound from Allium plants, on experimentally induced hepatic prefibrogenic events in Wistar rat.
    Nissar AU; Farrukh MR; Kaiser PJ; Rafiq RA; Afnan Q; Bhushan S; Adil HS; Subhash BC; Tasduq SA
    Phytomedicine; 2013 Jul; 20(10):828-33. PubMed ID: 23578993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective effects of naturally fermented noni juice against thioacetamide-induced liver fibrosis in rats.
    Lin YL; Lin HW; Chen YC; Yang DJ; Li CC; Chang YY
    J Chin Med Assoc; 2017 Apr; 80(4):212-221. PubMed ID: 28268174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icariin protects against thioacetamide-induced liver fibrosis in rats: Implication of anti-angiogenic and anti-autophagic properties.
    Algandaby MM; Breikaa RM; Eid BG; Neamatallah TA; Abdel-Naim AB; Ashour OM
    Pharmacol Rep; 2017 Aug; 69(4):616-624. PubMed ID: 28505603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-inflammatory and anti-fibrotic effects of tadalafil in thioacetamide-induced liver fibrosis in rats.
    Mansour HM; Salama AAA; Abdel-Salam RM; Ahmed NA; Yassen NN; Zaki HF
    Can J Physiol Pharmacol; 2018 Dec; 96(12):1308-1317. PubMed ID: 30398909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.